AmerisourceBergen stock soars to all-time high of $253.67

AmerisourceBergen (NYSE:COR) Corporation (NYSE: ABC) has reached a remarkable milestone, with its stock price soaring to an all-time high of $253.67. According to InvestingPro data, the company boasts a substantial market capitalization of $48.9 billion and maintains an impressive "GREAT" overall financial health score of 3.28/5. This peak reflects a significant vote of confidence from investors, as the company continues to outperform in its sector. Over the past year, AmerisourceBergen has seen an impressive 1-year change, with its stock value climbing by 16.16%. The company's commitment to shareholder returns is evident through its 20-year streak of dividend increases, with a current dividend yield of 0.89%. This growth trajectory underscores the company's robust financial health and its strong position within the pharmaceutical distribution industry, signaling a positive outlook for its future performance. For deeper insights into ABC's valuation and 15+ additional ProTips, explore the comprehensive Pro Research Report available on InvestingPro.

In other recent news, Cencora, Inc. has reported a 15% year-over-year increase in earnings and revenue for fiscal 2024's Q4. The adjusted diluted EPS for Q4 rose by 17% to $3.34, and consolidated revenue reached $79.1 billion. Following the acquisition of Retina Consultants of America (RCA), Cencora revised its fiscal year 2025 adjusted earnings per share (EPS) guidance upwards. The RCA acquisition is expected to contribute approximately $0.35 to earnings in its first year.

Mizuho (NYSE:MFG) recently gave Cencora an Outperform rating with a target price of $280, based on a 16 times price-to-earnings (P/E) multiple of the projected calendar year 2026 earnings per share (EPS) of $17.00. BofA Securities also revised its stock price target for Cencora to $260 from $255.

In other company news, Cencora announced the retirement of two long-standing board members, Richard W. Gochnauer and Kathleen W. Hyle. They will retire from their positions at the next Annual Meeting of Stockholders, scheduled for March 6, 2025. The company stated that there were no disagreements leading to their decisions to retire. These are the recent developments regarding Cencora, Inc.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.